| Dr Michael P Lin, MD | |
|
200 S Manchester Ave Ste 650, Orange, CA 92868-3224 | |
| (714) 456-5253 | |
| Not Available |
| Full Name | Dr Michael P Lin |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 18 Years |
| Location | 200 S Manchester Ave Ste 650, Orange, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144491176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | A102900 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Baron & Budd, P.C. attorney John Langdoc expressed his support and enthusiasm for a new and innovative initiative by the Washington, D.C.-based Lung Cancer Alliance —called Give a Scan—to make CT Scans and clinical data donated by cancer patients easily accessible to lung cancer researchers. LCA would "de-identify" the scans and data before making the information available to researchers.
Taking a dietary supplement of organic zinc and the enzyme phytase four days before receiving botulinum toxin injections made the toxin more effective in 93 percent of patients tested in a recent study at The Methodist Hospital in Houston.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.
Nearly 11 percent of people admitted to an intensive care unit in Sweden between 2010 and 2018 received opioid prescriptions on a regular basis for at least six months and up to two years after discharge.
› Verified 9 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Baron & Budd, P.C. attorney John Langdoc expressed his support and enthusiasm for a new and innovative initiative by the Washington, D.C.-based Lung Cancer Alliance —called Give a Scan—to make CT Scans and clinical data donated by cancer patients easily accessible to lung cancer researchers. LCA would "de-identify" the scans and data before making the information available to researchers.
Taking a dietary supplement of organic zinc and the enzyme phytase four days before receiving botulinum toxin injections made the toxin more effective in 93 percent of patients tested in a recent study at The Methodist Hospital in Houston.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.
Nearly 11 percent of people admitted to an intensive care unit in Sweden between 2010 and 2018 received opioid prescriptions on a regular basis for at least six months and up to two years after discharge.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael P Lin, MD 200 S Manchester Ave Ste 650, Orange, CA 92868 Ph: (714) 456-5253 | Dr Michael P Lin, MD 200 S Manchester Ave Ste 650, Orange, CA 92868-3224 Ph: (714) 456-5253 |
News Archive
Baron & Budd, P.C. attorney John Langdoc expressed his support and enthusiasm for a new and innovative initiative by the Washington, D.C.-based Lung Cancer Alliance —called Give a Scan—to make CT Scans and clinical data donated by cancer patients easily accessible to lung cancer researchers. LCA would "de-identify" the scans and data before making the information available to researchers.
Taking a dietary supplement of organic zinc and the enzyme phytase four days before receiving botulinum toxin injections made the toxin more effective in 93 percent of patients tested in a recent study at The Methodist Hospital in Houston.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.
Nearly 11 percent of people admitted to an intensive care unit in Sweden between 2010 and 2018 received opioid prescriptions on a regular basis for at least six months and up to two years after discharge.
› Verified 9 days ago
Xuan-binh D Pham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 W La Veta Ave Ste 320, Orange, CA 92868 Phone: 714-598-1194 | |
Dr. Douglas Albert Brownell, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1140 W La Veta Ave Ste 850, Orange, CA 92868 Phone: 714-997-4961 Fax: 714-560-4455 | |
Dr. Eric Owen Yeates, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Shray Malik, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3800 W Chapman Ave Ste 6200, Orange, CA 92868 Phone: 714-456-6262 | |
John Clifford German, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 396 S Main St Ste 200, Orange, CA 92868 Phone: 714-361-4480 Fax: 714-361-4490 | |
Michael J Stamos, MD Surgery Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-8978 | |
Dr. Eric James Kuncir, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 City Blvd W, Suite 1600, Orange, CA 92868 Phone: 714-456-5890 Fax: 714-456-6048 |